Mark Zalupski Selected Research

Mark Zalupski Research Topics

6	Neoplasms (Cancer) 01/2012 - 02/2002
5	Adenocarcinoma 01/2020 - 04/2005
4	Pancreatic Neoplasms (Pancreatic Cancer) 12/2016 - 03/2011
1	Hypertension (High Blood Pressure) 12/2016
1	Disease Progression 06/2014
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2009
1	Hepatocellular Carcinoma (Hepatoma) 09/2009
1	Hand-Foot Syndrome 04/2007
1	Infections 04/2007
1	Cholangiocarcinoma 11/2006
1	Colorectal Neoplasms (Colorectal Cancer) 07/2006
1	Carcinoma (Carcinomatosis) 04/2005
1	Sarcoma (Soft Tissue Sarcoma) 05/2004
1	Leiomyosarcoma 05/2004
1	Stomach Neoplasms (Stomach Cancer) 02/2003

8	Gemcitabine FDA Link 01/2020 - 05/2004
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 04/2005
2	Biomarkers (Surrogate Marker)IBA 12/2016 - 06/2014
2	Bevacizumab (Avastin)FDA Link 12/2016 - 06/2014
2	Lapatinib (GW572016)FDA Link 01/2012 - 09/2009
2	Docetaxel (Taxotere)FDA Link 03/2011 - 05/2004
2	Carboplatin (JM8)FDA LinkGeneric 04/2005 - 02/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2005 - 02/2003
1	veliparibIBA 01/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	Serum AlbuminIBA 06/2014
1	thiamine triphosphorate (TTP)IBA 06/2014
1	Cetuximab (Erbitux)FDA Link 09/2012
1	ixabepilone (BMS 247550)FDA Link 09/2012
1	margatoxinIBA 03/2011
1	Capecitabine (Xeloda)FDA Link 03/2011
1	Proteins (Proteins, Gene)FDA Link 09/2009
1	Leucovorin (Folinic Acid)FDA Link 04/2007
1	5-chloroquinoxaline-2-sulfanilamide (chloroquinoxaline sulfonamide)IBA 07/2006
1	Platinum Compounds (Compounds, Platinum)IBA 02/2003

6	Therapeutics 01/2020 - 02/2003
3	Radiotherapy 11/2009 - 02/2002
2	Drug Therapy (Chemotherapy) 01/2012 - 02/2002
2	Combination Drug Therapy (Combination Chemotherapy) 04/2005 - 02/2003
1	Neoadjuvant Therapy 01/2020